Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study

Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study

Abstract Background Although lung adenocarcinoma with activating epidermal growth factor receptor (EGFR) mutations is common in never smokers, one-third of the patients are ever-smokers. We aimed to investigate the effect of cumulative smoking dose(CSD) on clinical outcomes, including progression-fr...

Full description

Bibliographic Details
Main Authors: In Ae Kim, Jong Sik Lee, Hee Joung Kim, Wan Seop Kim, Kye Young Lee
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cancer
Subjects:
Cumulative smoking dose
EGFR mutations
EGFR-TKIs
Lung adenocarcinoma
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12885-018-4691-0

Internet

http://link.springer.com/article/10.1186/s12885-018-4691-0

Similar Items